Abg Innovation Capital Partners Iii Gp LTD Aadi Bioscience, Inc. Transaction History
Abg Innovation Capital Partners Iii Gp LTD
- $837,000
- Q2 2024
A detailed history of Abg Innovation Capital Partners Iii Gp LTD transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Abg Innovation Capital Partners Iii Gp LTD holds 26,666 shares of AADI stock, worth $54,931. This represents 4.54% of its overall portfolio holdings.
Number of Shares
26,666
Previous 26,666
-0.0%
Holding current value
$54,931
Previous $62,000
38.71%
% of portfolio
4.54%
Previous 7.69%
Shares
1 transactions
Others Institutions Holding AADI
# of Institutions
68Shares Held
12MCall Options Held
9.4KPut Options Held
2.5K-
Avoro Capital Advisors LLC New York, NY2.85MShares$5.87 Million0.06% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$3.81 Million2.91% of portfolio
-
Satter Management Co., L.P.1.63MShares$3.36 Million4.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA766KShares$1.58 Million0.0% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC526KShares$1.08 Million1.41% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $43.3M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...